author_facet O'Shaughnessy, E M
Fahle, G A
Witebsky, F G
O'Shaughnessy, E M
Fahle, G A
Witebsky, F G
author O'Shaughnessy, E M
Fahle, G A
Witebsky, F G
spellingShingle O'Shaughnessy, E M
Fahle, G A
Witebsky, F G
Journal of Clinical Microbiology
Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
Microbiology (medical)
author_sort o'shaughnessy, e m
spelling O'Shaughnessy, E M Fahle, G A Witebsky, F G 0095-1137 1098-660X American Society for Microbiology Microbiology (medical) http://dx.doi.org/10.1128/jcm.35.7.1902-1903.1997 <jats:p>The results of amoxicillin-clavulanate (AUG) and ampicillin-sulbactam (A/S) susceptibility testing by three different susceptibility testing methods, the MicroScan, Etest, and Kirby-Bauer methods, for 61 consecutive isolates of ampicillin-resistant Escherichia coli from different patients were compared. There was poor correlation of results for the two agents, the most and least marked discrepancies being observed by the MicroScan method (86.9% susceptible to AUG and 4.9% susceptible to A/S) and the Kirby-Bauer method (39.4% susceptible to AUG and 32.8% susceptible to A/S), respectively. More organisms were susceptible to AUG than A/S, regardless of the susceptibility testing methodology. The results from a College of American Pathologists survey with one E. coli isolate tested at different institutions also indicated greater susceptibility to AUG than to A/S. These agents are thought to be equally efficacious clinically. The discrepancies observed among methods for each antimicrobial inhibitor combination and the discrepancies observed between the two agents by each testing method suggest that the breakpoints for these agents need to be reevaluated.</jats:p> Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli Journal of Clinical Microbiology
doi_str_mv 10.1128/jcm.35.7.1902-1903.1997
facet_avail Online
Free
finc_class_facet Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qY20uMzUuNy4xOTAyLTE5MDMuMTk5Nw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qY20uMzUuNy4xOTAyLTE5MDMuMTk5Nw
institution DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Zi4
DE-Gla1
DE-15
DE-Pl11
DE-Rs1
DE-14
DE-105
imprint American Society for Microbiology, 1997
imprint_str_mv American Society for Microbiology, 1997
issn 1098-660X
0095-1137
issn_str_mv 1098-660X
0095-1137
language English
mega_collection American Society for Microbiology (CrossRef)
match_str oshaughnessy1997correlationofinvitrosusceptibilityresultsforamoxicillinclavulanateandampicillinsulbactamtestedagainstescherichiacoli
publishDateSort 1997
publisher American Society for Microbiology
recordtype ai
record_format ai
series Journal of Clinical Microbiology
source_id 49
title Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
title_unstemmed Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
title_full Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
title_fullStr Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
title_full_unstemmed Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
title_short Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
title_sort correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against escherichia coli
topic Microbiology (medical)
url http://dx.doi.org/10.1128/jcm.35.7.1902-1903.1997
publishDate 1997
physical 1902-1903
description <jats:p>The results of amoxicillin-clavulanate (AUG) and ampicillin-sulbactam (A/S) susceptibility testing by three different susceptibility testing methods, the MicroScan, Etest, and Kirby-Bauer methods, for 61 consecutive isolates of ampicillin-resistant Escherichia coli from different patients were compared. There was poor correlation of results for the two agents, the most and least marked discrepancies being observed by the MicroScan method (86.9% susceptible to AUG and 4.9% susceptible to A/S) and the Kirby-Bauer method (39.4% susceptible to AUG and 32.8% susceptible to A/S), respectively. More organisms were susceptible to AUG than A/S, regardless of the susceptibility testing methodology. The results from a College of American Pathologists survey with one E. coli isolate tested at different institutions also indicated greater susceptibility to AUG than to A/S. These agents are thought to be equally efficacious clinically. The discrepancies observed among methods for each antimicrobial inhibitor combination and the discrepancies observed between the two agents by each testing method suggest that the breakpoints for these agents need to be reevaluated.</jats:p>
container_issue 7
container_start_page 1902
container_title Journal of Clinical Microbiology
container_volume 35
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792332868018503690
geogr_code not assigned
last_indexed 2024-03-01T14:03:42.571Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Correlation+of+in+vitro+susceptibility+results+for+amoxicillin-clavulanate+and+ampicillin-sulbactam+tested+against+Escherichia+coli&rft.date=1997-07-01&genre=article&issn=1098-660X&volume=35&issue=7&spage=1902&epage=1903&pages=1902-1903&jtitle=Journal+of+Clinical+Microbiology&atitle=Correlation+of+in+vitro+susceptibility+results+for+amoxicillin-clavulanate+and+ampicillin-sulbactam+tested+against+Escherichia+coli&aulast=Witebsky&aufirst=F+G&rft_id=info%3Adoi%2F10.1128%2Fjcm.35.7.1902-1903.1997&rft.language%5B0%5D=eng
SOLR
_version_ 1792332868018503690
author O'Shaughnessy, E M, Fahle, G A, Witebsky, F G
author_facet O'Shaughnessy, E M, Fahle, G A, Witebsky, F G, O'Shaughnessy, E M, Fahle, G A, Witebsky, F G
author_sort o'shaughnessy, e m
container_issue 7
container_start_page 1902
container_title Journal of Clinical Microbiology
container_volume 35
description <jats:p>The results of amoxicillin-clavulanate (AUG) and ampicillin-sulbactam (A/S) susceptibility testing by three different susceptibility testing methods, the MicroScan, Etest, and Kirby-Bauer methods, for 61 consecutive isolates of ampicillin-resistant Escherichia coli from different patients were compared. There was poor correlation of results for the two agents, the most and least marked discrepancies being observed by the MicroScan method (86.9% susceptible to AUG and 4.9% susceptible to A/S) and the Kirby-Bauer method (39.4% susceptible to AUG and 32.8% susceptible to A/S), respectively. More organisms were susceptible to AUG than A/S, regardless of the susceptibility testing methodology. The results from a College of American Pathologists survey with one E. coli isolate tested at different institutions also indicated greater susceptibility to AUG than to A/S. These agents are thought to be equally efficacious clinically. The discrepancies observed among methods for each antimicrobial inhibitor combination and the discrepancies observed between the two agents by each testing method suggest that the breakpoints for these agents need to be reevaluated.</jats:p>
doi_str_mv 10.1128/jcm.35.7.1902-1903.1997
facet_avail Online, Free
finc_class_facet Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qY20uMzUuNy4xOTAyLTE5MDMuMTk5Nw
imprint American Society for Microbiology, 1997
imprint_str_mv American Society for Microbiology, 1997
institution DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105
issn 1098-660X, 0095-1137
issn_str_mv 1098-660X, 0095-1137
language English
last_indexed 2024-03-01T14:03:42.571Z
match_str oshaughnessy1997correlationofinvitrosusceptibilityresultsforamoxicillinclavulanateandampicillinsulbactamtestedagainstescherichiacoli
mega_collection American Society for Microbiology (CrossRef)
physical 1902-1903
publishDate 1997
publishDateSort 1997
publisher American Society for Microbiology
record_format ai
recordtype ai
series Journal of Clinical Microbiology
source_id 49
spelling O'Shaughnessy, E M Fahle, G A Witebsky, F G 0095-1137 1098-660X American Society for Microbiology Microbiology (medical) http://dx.doi.org/10.1128/jcm.35.7.1902-1903.1997 <jats:p>The results of amoxicillin-clavulanate (AUG) and ampicillin-sulbactam (A/S) susceptibility testing by three different susceptibility testing methods, the MicroScan, Etest, and Kirby-Bauer methods, for 61 consecutive isolates of ampicillin-resistant Escherichia coli from different patients were compared. There was poor correlation of results for the two agents, the most and least marked discrepancies being observed by the MicroScan method (86.9% susceptible to AUG and 4.9% susceptible to A/S) and the Kirby-Bauer method (39.4% susceptible to AUG and 32.8% susceptible to A/S), respectively. More organisms were susceptible to AUG than A/S, regardless of the susceptibility testing methodology. The results from a College of American Pathologists survey with one E. coli isolate tested at different institutions also indicated greater susceptibility to AUG than to A/S. These agents are thought to be equally efficacious clinically. The discrepancies observed among methods for each antimicrobial inhibitor combination and the discrepancies observed between the two agents by each testing method suggest that the breakpoints for these agents need to be reevaluated.</jats:p> Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli Journal of Clinical Microbiology
spellingShingle O'Shaughnessy, E M, Fahle, G A, Witebsky, F G, Journal of Clinical Microbiology, Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli, Microbiology (medical)
title Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
title_full Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
title_fullStr Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
title_full_unstemmed Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
title_short Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
title_sort correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against escherichia coli
title_unstemmed Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
topic Microbiology (medical)
url http://dx.doi.org/10.1128/jcm.35.7.1902-1903.1997